| Literature DB >> 21375740 |
Thierry Joël Nangue1, Hilaire Macaire Womeni, Felicite Tchouanguep Mbiapo, Jacques Fanni, Linder Michel.
Abstract
BACKGROUND: Dietary saturated fatty acids (SFAs) are generally considered to increase plasma cholesterol. It has also been claimed that they increase cardio-vascular disease, although the claim that some of SFAs can increase HDL-cholesterol is poorly documented. Irvingia gabonensis kernels after being dried and crushed they are generally used to prepare a sticky and aromatic soup very much consumed in Cameroun and West Africa countries. This study was therefore aimed at evaluating the effects of dika nut fat on the growing and lipids metabolism of young rats.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21375740 PMCID: PMC3060135 DOI: 10.1186/1476-511X-10-43
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Composition of rats diets during adaptation period Telefo, [14]
| Ingredients | Quantity of ration/kg |
|---|---|
| Cornstarch | 678 |
| Flour of soya | 200 |
| Fish meal | 100 |
| Flour of bone | 10 |
| Soya oil | 1 |
| Cooking salt | 10 |
| Vitamin & mineral | 1 |
Composition of study diets
| Ingredients (g) | Test diets | |||
|---|---|---|---|---|
| Fat control | Low-dose | Mid-dose | High-dose | |
| Starch | 500 | 568 | 523 | 410 |
| Soya bean oil cake | 200 | 200 | 200 | 200 |
| Fish protein | 100 | 100 | 100 | 100 |
| Sucrose | 20 | 20 | 20 | 20 |
| Flour of bone | 20 | 20 | 20 | 20 |
| Cellulose | 15 | 15 | 15 | 15 |
| Salt (Nacl) | 2 | 2 | 2 | 2 |
| Vitamin mix | 3 | 3 | 3 | 3 |
| Choline (ml) | 2 | 2 | 2 | 2 |
| Soya oil | 80 | 0 | 0 | 0 |
| Dika nut fat | 0 | 50 | 70 | 120 |
Fatty acid composition of test diets (gram of total weight of fat)
| Fatty acids | Test diets | |||
|---|---|---|---|---|
| Fat control | Low-dose | Mid-dose | High-dose | |
| C10:0 | 0.77 | 1.08 | 1.85 | |
| C12:0 | 20.35 | 28.49 | 48.84 | |
| C14:0 | 0.06 | 24.53 | 34.34 | 58.86 |
| C16:0 | 8.81 | 2.53 | 3.54 | 6.07 |
| C18:0 | 21.96 | 1.19 | 1.67 | 2.86 |
| C18:1 | 0.25 | 0.34 | 0.59 | |
| C18:2 n-6 | 42.29 | |||
| C18:3 n-3 | 5.62 | |||
| C20:0 | 0.30 | |||
| C22:0 | 0.26 | |||
| UI | 0.71 | 0.39 | 0.55 | 0.94 |
| SFA (g) | 9.42 | 49.37 | 69.11 | 118.48 |
| PUFA (g) | 69.86 | 0.25 | 0.34 | 0.59 |
| Total weight fat | 80 | 50 | 70 | 120 |
UI: Unidentified
Fatty acids profile of dika nut fat
| Symbols | Fatty acid level (%) |
|---|---|
| C10:0 | 1.54 |
| C12:0 | 40.70 |
| C14:0 | 49.05 |
| C16:0 | 5.06 |
| C18:0 | 2.38 |
| C18:1n9 | 0.49 |
| UI | 0.78 |
| SFA | 98.73 |
| UFA | 0.49 |
UI: Unidentified
Food intake data (g) during experimentation period for male and female rats
| Weeks | ||||
|---|---|---|---|---|
| Diets | M ± SEM | |||
| IG0 | 7.39 ± 3.49 | 26.89 ± 4.52 | 40.57 ± 7.24 | 19.88 ± 14.26 |
| IG1 | 10.28 ± 5.48a** | 24.82 ± 8.69a | 30.14 ± 9.36a | 18.81 ± 11.09a |
| IG2 | 7.60 ± 5.01b | 27.71 ± 6.69a,b | 42.36 ± 9.80b | 20.59 ± 15.53a |
| IG3 | 9.19 ± 3.38a,b | 30.05 ± 6.32b | 32.79 ± 10.91a,b | 21.15 ± 13.87a |
| IG0 | 9.91 ± 4.13 | 26.88 ± 6.42 | 44.95 ± 10.96 | 22.01 ± 15.21 |
| IG1 | 7.72 ± 3.26a | 28.71 ± 5.44a | 30.14 ± 9.36a | 22.97 ± 20.02a |
| IG2 | 11.03 ± 7.29b | 24.91 ± 5.07a | 42.36 ± 9.80a,b | 20.87 ± 13.65a |
| IG3 | 10.18 ± 3.60a,b | 27.43 ± 7.34a | 32.79 ± 10.91b | 20.92 ± 12.86a |
S1, S2 and S3 (week 1, week 2 and week 3 respectively
IG0: control diet with 80 g of soya fat; IG1: test 1 diet with 50 g of dika nut fat
IG2: test2 diet with 70 g of dika nut fat; IG3: test3 diet with 120 g of dika nut fat
In the columns, the values affected of the same letter are not significantly different (P > 0.05) and the value with different letter are significantly different (P < 0.05). (Bonferroni between treated animals).
* Significantly different from fat control in the same sex (P < 0.05). (Dunnett's)
**significantly different from fat control in the same sex (p < 0.01). (Dunnett's)
Food indices consumption data (g) during treated period for male and female
| Diets | Weeks | |||
|---|---|---|---|---|
| M ± SEM | ||||
| IG0 | 1.11 ± 0.65 | 1.00 ± 0.34 | 0.72 ± 0.10 | 1.00 ± 0.52 |
| IG1 | 1.32 ± 0.80a | 0.89 ± 0.23a | 0.56 ± 0.23a | 1.04 ± 0.66a |
| IG2 | 1.44 ± 1.15a | 0.93 ± 0.31a | 0.69 ± 0.13a | 1.14 ± 0.88a |
| IG3 | 1.82 ± 1.71a* | 0.95 ± 0.38a | 0.61 ± 0.19a | 1.32 ± 1.33a |
| IG0 | 1.25 ± 0.61 | 0.83 ± 0.16 | 0.77 ± 0.22 | 1.02 ± 0.50 |
| IG1 | 1.58 ± .19a | 0.94 ± 0.24a | 0.87 ± 0.27a | 1.26 ± 0.92a |
| IG2 | 1.83 ± 1.14a** | 1.04 ± 0.54a | 0.77 ± 0.17a | 1.38 ± 0.97a** |
| IG3 | 1.49 ± 1.01a | 0.87 ± 0.25a | 0.70 ± 0.13a | 1.15 ± 0.80a |
In the columns, the values affected of the same letter are not significantly different (P > 0.05) and the value with different letter are significantly different (P < 0.05). (Bonferroni between treated animals).
* Significantly different from fat control in the same sex (P < 0.05). (Dunnett's)
**significantly different from fat control in the same sex (p < 0.01). (Dunnett's)
Figure 1Male body weight gain (%) during experimental period . Each point represents a mean between 5 observations
Figure 2Female body weight gain (%) during experimental period . Each point represents a mean between 5 observations
Weight gain (%) during the three weeks treatment for males and females
| Diets | Weeks | |||
|---|---|---|---|---|
| M ± SEM | ||||
| IG0 | 27.12 ± 18.11 | 95.28 ± 38.75 | 181.85 ± 49.95 | 78.52 ± 68.27 |
| IG1 | 29.8 ± 18.01a | 95.15 ± 35.30a | 180.08 ± 57.01a | 79.43 ± 67.19a |
| IG2 | 24.62 ± 19.04a | 112.15 ± 47.67a,b | 215.08 ± 61.56a,b | 90.17 ± 83.77a |
| IG3 | 29.5 ± 20.47a | 141.65 ± 48.22b** | 253.96 ± 49.11b** | 108.03 ± 95.67a** |
| IG0 | 29.22 ± 15.65 | 26.88 ± 6.42 | 194.12 ± 31.25 | 86.85 ± 69.31 |
| IG1 | 21.74 ± 13.52a** | 28.72 ± 5.44a | 187.58 ± 17.59a | 76.68 ± 66.78a** |
| IG2 | 32.85 ± 17.84a,b | 24.92 ± 5.07a | 205.26 ± 45.39a,b | 93.20 ± 72.93a* |
| IG3 | 34.82 ± 19.87b** | 27.44 ± 7.35a | 216.68 ± 34.59b* | 98.00 ± 76.67a** |
In the columns, the values affected of the same letter are not significantly different (P > 0.05) and the value with different letter are significantly different (P < 0.05). (Bonferroni between treated animals).
* Significantly different from fat control in the same sex (P < 0.05). (Dunnett's)
**significantly different from fat control in the same sex (p < 0.01). (Dunnett's)
Influence of the incorporation of Irvingia gabonensis fat on the relative weight of some vital organs for male and female rats
| Diets | Organs (g) | ||||
|---|---|---|---|---|---|
| liver | lungs | kidney | spleen | heart | |
| IG0 | 5.93 ± 0.79 | 1.00 ± 0.34 | 1.20 ± 0.26 | 0.35 ± 0.08 | 0.57 ± 0.14 |
| IG1 | 4.75 ± 0.50a** | 0.84 ± 0.05a | 1.49 ± 0.36a | 0.36 ± 0.08a | 0.52 ± 0.03a |
| IG2 | 4.75 ± 0.16a** | 0.82 ± 0.11a | 1.09 ± 0.28a | 0.28 ± 0.04a | 0.47 ± 0.04a |
| IG3 | 4.85 ± 0.18a** | 1.28 ± 0.80a | 1.17 ± 0.30a | 0.40 ± 0.21a | 0.54 ± 0.05a |
| IG0 | 0.50 ± 0.22 | 1.01 ± 0.26 | 1.33 ± 0.19 | 0.31 ± 0.07 | 0.51 ± 0.08 |
| IG1 | 4.98 ± 0.35a | 1.07 ± 0.23a | 1.27 ± 0.17a | 0.42 ± 0.08a* | 0.54 ± 0.05a |
| IG2 | 4.93 ± 0.32a | 0.91 ± 0.05a | 1.34 ± 0.12a | 0.32 ± 0.06a | 0.55 ± 0.04a |
| IG3 | 5.07 ± 0.46a | 0.88 ± 0.13a | 1.40 ± 0.51a | 0.32 ± 0.05a | 0.55 ± 0.07a |
In the columns, the values affected of the same letter are not significantly different (P > 0.05) and the value with different letter are significantly different (P < 0.05). (Bonferroni between treated animals).
* Significantly different from fat control in the same sex (P < 0.05). (Dunnett's)
**significantly different from fat control in the same sex (p < 0.01). (Dunnett's)
Influence of the incorporation fat Irvingia gabonensis on some toxicology parameter for male and female rats
| Diets | ALT (U/L) | AST (U/L) | Serum protein (mg/ml) | Hepatic protein (mg/g) |
|---|---|---|---|---|
| IG0 | 16.36 ± 8.83 | 26.81 ± 8.02 | 134.18 ± 18.17 | 123.04 ± 6.84 |
| IG1 | 17.98 ± 4.36a | 21.81 ± 0.51a | 82.03 ± 11.12a** | 255.70 ± 11.32a** |
| IG2 | 14.44 ± 3.35a | 17.97 ± 3.35a | 128.10 ± 21.15b | 238.99 ± 8.51a** |
| IG3 | 16.29 ± 4.16a | 33.29 ± 17.24a | 100.25 ± 9.23a,b* | 138.23 ± 11.55b |
| IG0 | 10.02 ± 5.89 | 109.62 ± 43.91 | 97.72 ± 17.77 | 333.16 ± 21.08 |
| IG1 | 22.10 ± 10.04a | 22.68 ± 12.07a* | 117.47 ± 16.85a | 293.67 ± 15.50a* |
| IG2 | 7.37 ± 1.02a | 44.79 ± 34.29a* | 113.92 ± 10.89a | 174.69 ± 14.09a** |
| IG3 | 15.32 ± 3.68a | 38.83 ± 6.27a* | 141.77 ± 19.53a** | 206.58 ± 19.49b** |
AST, aspartate aminotransferase, ALT, alanine aminotransferase
In the columns, the values affected of the same letter are not significantly different (P > 0.05) and the value with different letter are significantly different (P < 0.05). (Bonferroni between treated animals).
* Significantly different from fat control in the same sex (P < 0.05). (Dunnett's)
**significantly different from fat control in the same sex (p < 0.01). (Dunnett's)
Influence of the incorporation of dika nut fat on some clinical parameter for males and females rats
| Diets | Total Cholesterol | HDL-cholesterol | Triglycerides | LDL-cholesterol |
|---|---|---|---|---|
| Mg/dl | ||||
| IG0 | 147.56 ± 7.02 | 82.08 ± 5.68 | 120.98 ± 9.56 | 58.232 ± 10.35 |
| IG1 | 134.70 ± 19.65 | 78.66 ± 6.43a | 130.24 ± 9.33 | 43.72 ± 19.58a |
| IG2 | 193.64 ± 7.581** | 84.71 ± 2.16a | 143.58 ± 4.59* | 82.57 ± 12.23b |
| IG3 | 186.32 ± 7.851** | 85.96 ± 3.53a | 181.90 ± 14.972** | 69.95 ± 9.39b |
| IG0 | 138.10 ± 10.52 | 65.79 ± 12.67 | 104.00 ± 16.98 | 58.71 ± 12.99 |
| IG1 | 160.31 ± 10.18a,b | 67.10 ± 10.66a | 137.40 ± 7.61a** | 65.72 ± 6.39a |
| IG2 | 151.67 ± 6.47a | 71.86 ± 10.41a | 157.61 ± 10.65a** | 48.29 ± 4.63b |
| IG3 | 176.25 ± 21.8b** | 92.94 ± 5.65b** | 156.49 ± 11.40a** | 54.01 ± 6.96a |
-In the columns, the values affected of the same letter are not significantly different (P > 0.05) and the value with different letter are significantly different (P < 0.05). (Bonferroni between treated animals).
-In the columns, the values affected of the same number are not significantly different (P > 0.05)
1 Significantly higher in comparison to IG1 group for male between treated animals (P < 0.001) (Bonferroni)
2 Significantly higher in comparison to IG1 and IG2 groups for male between treated animals (P < 0.001) (Bonferroni)
* Significantly different from fat control in the same sex (P < 0.05). (Dunnett's)
** Significantly different from fat control in the same sex (p < 0.01). (Dunnett's